IMMUNOCELLULAR THERAPEUTICS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IMMUNOCELLULAR THERAPEUTICS *W EXP 08/12/202, CUSIP 452536121.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IMMUNOCELLULAR THERAPEUTICS *W EXP 08/12/202, CUSIP 452536121.